Anti-PD-1 bispecifics
搜索文档
Medicenna Therapeutics (OTCPK:MDNA.F) 2026 Conference Transcript
2026-04-22 04:02
Medicenna Therapeutics (OTCPK:MDNA.F) 2026 Conference April 21, 2026 03:00 PM ET Company ParticipantsFahar Merchant - President and CEOFahar MerchantOkay. Thank you everyone for attending this session. My name is Fahar Merchant. I'm President and CEO of Medicenna. First, I'd like to thank Bloom Burton for inviting us today to present. I look forward to sharing with you our programs in the clinic, including an exciting new program that we just presented, or just finished presenting in San Diego two minutes a ...